Epinay sur Seine, France

Christain L Renault

This inventor holds 1 USPTO granted patent. Top assignee: Pharmindustrie. Active years: 1981.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Christain L Renault. Retrieved from https://idiyas.com/inventor/christain-l-renault

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 2.0

ph-index = 1

Forward Citations = 9(Granted Patents)


Company Filing History:


Years Active: 1981

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Christain L Renault: Innovator in Medicinal Chemistry

Introduction

Christain L Renault is a notable inventor based in Epinay sur Seine, France. He has made significant contributions to the field of medicinal chemistry, particularly through his innovative patent related to hypolipemiants and psychostimulants.

Latest Patents

Renault holds a patent for "2-Pyrrolidine methanol derivatives utilizable as medicaments." This patent discloses compounds of a specific formula, where X can be a hydrogen or halogen atom, or an alkoxy group with 1 to 4 carbon atoms. The compounds also include alkyl or cycloalkyl groups with 1 to 8 carbon atoms. R represents a hydrogen atom, an alkyl group with 1 to 4 carbon atoms, or an aralkyl or hydroxyalkyl group with a similar alkyl chain length. These compounds are not only useful as medicaments but also exhibit properties as hypolipemiants and some as psychostimulants.

Career Highlights

Renault is associated with Pharmindustrie, where he applies his expertise in medicinal chemistry. His work focuses on developing innovative compounds that can lead to new therapeutic options in medicine.

Collaborations

Renault collaborates with Jean-Jacques Legrand, contributing to advancements in their field through shared knowledge and expertise.

Conclusion

Christain L Renault's work exemplifies the impact of innovation in medicinal chemistry, showcasing how his patents can lead to significant advancements in healthcare.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…